FGFrancisca Elena Zavaleta Gutiérrez

Francisca Elena Zavaleta Gutiérrez

*This is an algorithmically generated author record based on publicly available information.

Francisca Elena Zavaleta Gutiérrez has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A comprehensive review of genetic causes of obesity

    by Marcio José Concepción-Zavaleta, Juan Eduardo Quiroz-Aldave, María del Carmen Durand-Vásquez, Elman Rolando Gamarra-Osorio, Juan del Carmen Valencia de la Cruz, Claudia Mercedes Barrueto-Callirgos, Susan Luciana Puelles-León, Elena de Jesús Alvarado-León, Frans Leiva-Cabrera, Francisca Elena Zavaleta-Gutiérrez, et al.

    Background Obesity is a multifactorial chronic disease with a high, increasing worldwide prevalence. Genetic causes account for 7% of the cases in children with extreme obesity. Data sources This narrative review was conducted by searching for papers published in the PubMed/MEDLINE, Embase and SciELO databases and included 161 articles. The search used the following search terms: “obesity”, “obesity and genetics”, “leptin”, “Prader-Willi syndrome”, and “melanocortins”. The types of studies included were systematic reviews, clinical trials, prospective cohort studies, cross-sectional and prospective studies, narrative reviews, and case reports. Results The leptin-melanocortin pathway is primarily responsible for the regulation of appetite and body weight. However, several important aspects of the pathophysiology of obesity remain unknown. Genetic causes of obesity can be grouped into syndromic, monogenic, and polygenic causes and should be assessed in children with extreme obesity before the age of 5 years, hyperphagia, or a family history of extreme obesity. A microarray study, an analysis of the melanocortin type 4 receptor gene mutations and leptin levels should be performed for this purpose. There are three therapeutic levels: lifestyle modifications, pharmacological treatment, and bariatric surgery. Conclusions Genetic study technologies are in constant development; however, we are still far from having a personalized approach to genetic causes of obesity. A significant proportion of the affected individuals are associated with genetic causes; however, there are still barriers to its approach, as it continues to be underdiagnosed. Video Abstract (MP4 1041807 KB)


  • Open Access

    Arterial blood gas and retinopathy in very low birth weight premature infants

    by Martina Rosaria Huamán-Rodríguez, Francisca Elena Zavaleta-Gutierrez, Jorge Luis Tapia-Zerpa, Víctor Andrés Sánchez-Reyna, Edi William Aguilar-Urbina

    Objetivo: Determinar si las alteraciones de la gasometría arterial están asociadas a retinopatía en prematuros de muy bajo peso al nacer. Métodos: Estudio observacional, analítico, retrospectivo y longitudinal, diseño casos y controles. Se revisaron historias clínicas de prematuros nacidos en el Hospital Belén de Trujillo (2013-2017). La asociación entre cada alteración de la gasometría arterial y la retinopatía se evaluó con el test chi-cuadrado y para el ajuste al efecto de las restantes alteraciones, se usó el análisis multivariado de regresión logística. Resultados: : Fueron 49 casos y 147 controles. La hiperoxemia, la edad gestacional < 28 semanas, el peso al nacer < 1 000 gramos, la reanimación, la intubación, el Apgar < 7 al minuto y la ventilación mecánica estuvieron asociados a ROP (pConclusión: La hiperoxemia es la alteración gasométrica asociada a ROP, pero el factor que influye significativamente en la estimación de esta enfermedad es la edad gestacional < 28 semanas, la cual incrementa 7,34 veces el riesgo.

  • Open Access

    Cushing disease in pediatrics: an update

    by Marcio José Concepción-Zavaleta, Cristian David Armas, Juan Eduardo Quiroz-Aldave, Eilhart Jorge García-Villasante, Ana Cecilia Gariza-Solano, María del Carmen Durand-Vásquez, Luis Alberto Concepción-Urteaga, Francisca Elena Zavaleta-Gutiérrez

    Cushing disease (CD) is the main cause of endogenous Cushing syndrome (CS) and is produced by an adrenocorticotropic hormone (ACTH)-producing pituitary adenoma. Its relevance in pediatrics is due to the retardation of both growth and developmental processes because of hypercortisolism. In childhood, the main features of CS are facial changes, rapid or exaggerated weight gain, hirsutism, virilization, and acne. Endogenous hypercortisolism should be established after exogenous CS has been ruled out based on 24-hour urinary free cortisol, midnight serum or salivary cortisol, and dexamethasone suppression test; after that, ACTH dependence should be established. The diagnosis should be confirmed by pathology. The goal of treatment is to normalize cortisol level and reverse the signs and symptoms. Treatment options include surgery, medication, radiotherapy, or combined therapy. CD represents a challenge for physicians owing to its multiple associated conditions involving growth and pubertal development; thus, it is important to achieve an early diagnosis and treatment in order to control hypercortisolism and improve the prognosis. Its rarity in pediatric patients has led physicians to have limited experience in its management. The objective of this narrative review is to summarize the current knowledge about the pathophysiology, diagnosis, and treatment of CD in the pediatric population.


  • Open Access

    T3 therapy in hypothyroidism. Still more questions than answers

    by Marcio José Concepción Zavaleta, Julia Cristina Coronado Arroyo, Francisca Elena Zavaleta Gutiérrez, Luis Alberto Concepción Urteaga


  • Gestational diabetes during COVID 19 pandemic: Major problem is diagnosis

    by Marcio José Concepción Zavaleta, Julia Cristina Coronado Arroyo, Francisca Elena Zavaleta Gutiérrez, Luis Alberto Concepción Urteaga

  • Does level of education influence mortality of SARS-CoV-2 in a developing country?

    by Marcio José Concepción-Zavaleta, Julia Cristina Coronado-Arroyo, Francisca Elena Zavaleta-Gutiérrez, Luis Alberto Concepción-Urteaga


  • Requirement of a prompt solution to address infection and mortality due to COVID-19 among Peruvian physicians

    by Marcio José Concepción-Zavaleta, Diego Moreno Marreros, Julia Cristina Coronado Arroyo, Luis Alberto Concepción Urteaga, Francisca Elena Zavaleta Gutiérrez


  • Open Access

    COVID‐19 and Obesity: The Intersection Between a Pandemic and an Epidemic in a Developing Country

    by Marcio José Concepción‐Zavaleta, Claudia Gutiérrez‐Ortiz, Julia Cristina Coronado‐Arroyo, Francisca Elena Zavaleta‐Gutiérrez, Luis Alberto Concepción‐Urteaga

    We have read with great interest the prospective cohort study published by Czernichow et al 1, wherein they found that obesity doubles mortality in patients hospitalized with coronavirus disease (COVID‐19), using as an indicator anthropometric, the body mass index (BMI). Despite BMI being recognized as an anthropometric index of obesity and various studies confirming that it predicts cardiovascular events, the lack of information it provides on the distribution of body fat is considered its main limitation. The use of abdominal circumference and waist‐height ratio are better measures of visceral fat distribution, which is more closely associated with cardiometabolic risk;2 however, those measures demand greater contact with COVID‐19 patients.